DKDeborah de Camargo Hizume Kunzler

Deborah de Camargo Hizume Kunzler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Deborah de Camargo Hizume Kunzler has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lung-brain crosstalk: Behavioral disorders and neuroinflammation in septic survivor mice

    by Kelly Cattelan Bonorino, Scheila Iria Kraus, Gisele Henrique Cardoso Martins, Jéssica Jorge Probst, Débora Melissa Petry Moeke, Alice Henrique dos Santos Sumar, Yuri Reis Casal, Filipe Rodolfo Moreira Borges Oliveira, Regina Sordi, Jamil Assreuy, et al.


  • Crutch Load Monitoring System for an Adequate Rehabilitation

    by Alexandre Campos, Wladymir Kulkamp, Jaqueline de Souza, Rafael Campos, Deborah Kunzler

  • Comparing handgrip strength between judokas and non-judokas using population-based normative values

    by Wladymir Külkamp, Rafael Lima Kons, Jaqueline de Souza, Deborah Hizume-Kunzler, Jonathan Ache-Dias, Raiane Carvalho, Juliano Dal Pupo, Daniele Detanico

  • Concurrent Validity and Technological Error-Based Reliability of a Novel Device for Velocity-Based Training

    by Wladymir Külkamp, Chris Bishop, Rafael Kons, Lara Antunes, Evertoncrivoi Carmo, Deborah Hizume-Kunzler, Juliano Dal Pupo

    The aim of this study was to verify the concurrent validity and the biological error-free reliability of a novel low-cost commercial encoder (Ergonauta I). Validity protocol involved comparisons with a custom system and other encoder commercially available (Vitruve). Reliability protocols involved interdevices and interunit comparisons. No participants were recruited, and reliability assessments were performed in a Smith Machine by bar free fall tests. Our results showed a significant bias for mean velocity (MV) estimated by both encoders only in one of the four conditions investigated (bias = 0.05 m/s). Regarding sensitivity, the smallest detectable change suggests only values higher than 0.03 m/s must to be considered as real changes in performance, when monitoring MV and mean propulsive velocity (MPV) through Ergonauta I and Vitruve. Between-days intra-device reliability showed Ergonauta I remains highly reliable after one week for most assessments, whereas slightly less sensitive for peak velocity and peak power output.


  • Aerobic Exercise Attenuates Kidney Injury, Improves Physical Performance, and Increases Antioxidant Defenses in Lungs of Adenine-Induced Chronic Kidney Disease Mice

    by Débora Melissa Petry Moecke, Gisele Henrique Cardoso Martins, Thaine Cristina Garlet, Kelly Cattelan Bonorino, Marilia Gabriela Luciani, Monique Bion, Barbara dos Santos, Monique da Silva Gevaerd, Jamil Assreuy Filho, Adair Roberto Soares dos Santos, et al.

    The association between chronic kidney disease (CKD) and pulmonary pathophysiological changes is well stablished. Nevertheless, the effects of aerobic exercise (AE) on lungs of CKD need further clarification. Thus, Swiss mice were divided in control, AE, CKD, and CKD + AE groups. CKD was induced by 0.2% adenine intake during 8 weeks (4 weeks of CKD induction and 4 weeks of AE). AE consisted in running on treadmill, at moderate intensity, 30 min/day, 5 days/week, during 4 weeks. Twenty-four hours after the last training day, functional capacity test was performed, and 48 h after the test, mice were euthanized. CKD mice showed a significant increase in urine output, serum urea, and creatinine concentrations, and decreased body weight and urine density, besides oxidative damage (p = 0.044), edema area (p < 0.001), leukocyte infiltration (p = 0.040), and collagen area in lung tissue (p = 0.004). AE resulted in an increase of distance traveled (p = 0.049) and maximum speed (p = 0.046), increased activity of catalase (p = 0.031) and glutathione peroxidase (p = 0.048) in lungs, increased levels of nitric oxide (NOx) in serum (p = 0.001) and bronchoalveolar lavage fluid (p = 0.047), and decreased kidney histological injury (p = 0.018) of CKD mice. However, AE also increased oxidative damage (p = 0.003) and did not change collagen content or perivascular edema in lungs (p > 0.05) of CKD mice. Therefore, AE attenuated kidney injury and improved antioxidants defenses in lungs. Despite no significant changes in pulmonary damage, AE significantly improved physical performance in CKD mice.


  • Aerobic exercise ameliorates survival, clinical score, lung inflammation, DNA and protein damage in septic mice

    by Alice H.S. Sumar, Ariany M. Vieira, Gisele H.C. Martins, Jéssica J. Probst, Daniel F. Martins, Franciane Bobinski, Verônica V. Horewicz, Josiel M. Mack, Naissa M. Danielli, Mauricio P. Cunha, et al.


  • Retracted
    Open Access

    Retraction: Effects of physical exercise on lung inflammation in animal models of chronic allergic lung inflammation: a systematic review

    by Gisele Henrique Cardoso Martins, Juliete Palandi, Vitória Helena Kuhn DE Campos, Kelly Cattelan Bonorino, Deborah de Camargo Hizume Kunzler

    We performed a systematic review to identify and summarize the effects of distinctive aerobic exercise (AE) protocols on chronic allergic lung inflammation reported in asthma animal models. We identified 255 preclinical studies of asthma and AE protocols by comprehensive searches in PubMed, ScienceDirect and LILACS for peer-reviewed journals, using the search components “exercise,” “lung inflammation,” and “asthma,” without restrictions on publication date. Twenty-two studies were selected that met all eligibility criteria. Most studies used an ovalbumin experimental model and performed experiments with BALB/c mice. Most studies performed treadmill AE, using protocols of 30 to 60 minutes, 3 to 5 times/week, for 4 to 8 weeks. The results showed that the effects of AE on lungs were protocol dependent, but generaly, there was a decrease in inflammatory cell influx and Th2 cytokines, as well as an increase in anti-inflammatory defenses. However, the immunoregulation of globulins and nitric oxide levels in asthma seemed to be associated with the onset of AE. The results suggest that AE plays an important immunoregulatory role in animal models of asthma, with effects mainly mediated by increased anti-inflammatory defenses and reduced Th2 response. In parallel, prophylactic and therapeutic AE also played important roles in decreasing bronchial responsiveness and attenuating lung remodeling in animal models of asthma, secondary outcomes in this systematic review. The review protocol was published for free access in October 2017 on the Systematic Review Facility (SyRF) platform (http://syrf.org.uk/protocols/).


  • Pulmonary and muscle profile in pneumosepsis: A temporal analysis of inflammatory markers

    by Jéssica Jorge Probst, Gisele Henrique Cardoso Martins, Alice Henrique dos Santos Sumar, Ariany Marques Vieira, Monique Bion, Franciane Bobinski, Verônica Vargas Horewicz, Daniel Fernandes Martins, Adair Roberto Soares dos Santos, Kelly Catellan Bonorino, et al.


  • High-Intensity Exercise Prevents Disturbances in Lung Inflammatory Cytokines and Antioxidant Defenses Induced by Lipopolysaccharide

    by Gisele Henrique Cardoso, Débora Melissa Petry, Jéssica Jorge Probst, Luiz Felipe de Souza, Gabriella Ganguilhet, Franciane Bobinski, Adair R. S. Santos, Daniel Fernandes Martins, Kelly Cattelan Bonorino, Alcir Luiz Dafre, et al.

    In this study, we evaluated the effects of high-intensity swimming in an experimental model of acute lung injury (ALI) induced by lipopolysaccharide (LPS) on lung inflammation and antioxidant defenses. Balb/C male mice were submitted to exercise (30 min/day, 5 days/week, for a period of 3 weeks) prior to LPS instillation in the lung. Twenty-four hours after delivery of LPS (10 μg/animal), mice were euthanized and bronchoalveolar fluid (BALF) was obtained for cell counting and analysis of cytokines by ELISA. Lung tissue was used to evaluate antioxidant defenses. LPS instillation resulted in an increase in total and mononuclear cells, IL-1β, TNF-α, and IL-6 in BALF. LPS instillation also altered IL-10 and IL-ra levels in BALF and induced antioxidant defenses (glutathione, superoxide dismutase, catalase, and glutathione peroxidase) in the lung. Protein carbonyl increased in the LPS-treated animals. High-intensity swimming prevented all these changes induced by LPS. Significance: Therefore, this experimental protocol of high-intensity swimming showed a protective effect on ALI, decreasing inflammatory processes and preventing disturbances in antioxidant defenses into the lungs.


  • Aerobic Exercise Decreases Lung Inflammation by IgE Decrement in an OVA Mice Model

    by Deborah Camargo Hizume-Kunzler, Flavia R. Greiffo, Bárbara Fortkamp, Gabriel Ribeiro Freitas, Juliana Keller Nascimento, Thayse Regina Bruggemann, Leonardo Melo Avila, Adenir Perini, Franciane Bobinski, Morgana Duarte Silva, et al.

    Aerobic exercise (AE) reduces lung function decline and risk of exacerbations in asthmatic patients. However, the inflammatory lung response involved in exercise during the sensitization remains unclear. Therefore, we evaluated the effects of exercise for 2 weeks in an experimental model of sensitization and single ovalbumin-challenge. Mice were divided into 4 groups: mice non-sensitized and not submitted to exercise (Sedentary, n=10); mice non-sensitized and submitted to exercise (Exercise, n=10); mice sensitized and exposed to ovalbumin (OVA, n=10); and mice sensitized, submitted to exercise and exposed to OVA (OVA+Exercise, n=10). 24 h after the OVA/saline exposure, we counted inflammatory cells from bronchoalveolar fluid (BALF), lung levels of total IgE, IL-4, IL-5, IL-10 and IL-1ra, measurements of OVA-specific IgG1 and IgE, and VEGF and NOS-2 expression via western blotting. AE reduced cell counts from BALF in the OVA group (p<0.05), total IgE, IL-4 and IL-5 lung levels and OVA-specific IgE and IgG1 titers (p<0.05). There was an increase of NOS-2 expression, IL-10 and IL-1ra lung levels in the OVA groups (p<0.05). Our results showed that AE attenuated the acute lung inflammation, suggesting immunomodulatory properties on the sensitization process in the early phases of antigen presentation in asthma.